{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:58:06Z","timestamp":1761663486291},"reference-count":23,"publisher":"Japan Society for Clinical Immunology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2177\/jsci.39.213","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T20:46:31Z","timestamp":1466109991000},"page":"213-218","source":"Crossref","is-referenced-by-count":7,"title":["Retrospective investigation of side effects and prognoses of moderate-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia that developed in patients with autoimmune diseases"],"prefix":"10.2177","volume":"39","author":[{"given":"Tomohiko","family":"SHIBATA","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"TONOOKA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"TSUCHIDA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"MITOMI","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiko","family":"SHIBATA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naooki","family":"KATSUYAMA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sepkowitz, K.A.: Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. <i>Clin Infect Dis<\/i>. <b>34<\/b>: 1098-1107, 2002.","DOI":"10.1086\/339548"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ai, J.W., et al.: The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor- Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry\/Cohort Studies. <i>J Rheumatol<\/i>. <b>42<\/b>: 2229-2237, 2015.","DOI":"10.3899\/jrheum.150057"},{"key":"3","unstructured":"3) \u67f4\u7530\u670b\u5f66\uff0c\u4ed6\uff1a\u8056\u30de\u30ea\u30a2\u30f3\u30ca\u533b\u79d1\u5927\u5b66\u6a2a\u6d5c\u5e02\u897f\u90e8\u75c5\u9662\u306b\u304a\u3051\u308b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306eB\u578b\u809d\u708e\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u72b6\u6cc1\u3068\u518d\u6d3b\u6027\u5316\u306e\u8abf\u67fb\uff0e\u8056\u30de\u30ea\u30a2\u30f3\u30ca\u533b\u79d1\u5927\u5b66\u96d1\u8a8c\uff0e<b>43<\/b>: 81-86, 2015."},{"key":"4","unstructured":"4) Godeau, B., et al.: Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. <i>J Rheumatol<\/i>. <b>21<\/b>: 246-251, 1994."},{"key":"5","unstructured":"5) Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. October 9 2015. Available at http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf. (Updated September 10, 2015.)"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Thomas, M., et al.: Good outcome with trimethoprim 10 mg\/kg\/day-sulfamethoxazole 50 mg\/kg\/day for Pneumocystis jirovecii pneumonia in HIV infected patients. <i>Scand J Infect Dis<\/i>. <b>41<\/b>: 862-868, 2009.","DOI":"10.3109\/00365540903214256"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Creemers-Schild, D., et al.: Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study. <i>Infection<\/i>. Oct 15 [Epub ahead of print], 2015.","DOI":"10.1007\/s15010-015-0851-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Tokuda, H., et al.: Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study. <i>Intern Med<\/i>. <b>47<\/b>: 915-923, 2008.","DOI":"10.2169\/internalmedicine.47.0702"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Thomas, C.F. Jr., Limper, A.H.: Pneumocystis pneumonia. <i>N Engl J Med<\/i>. <b>350<\/b>: 2487-2498, 2004.","DOI":"10.1056\/NEJMra032588"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Chin, T.W., et al.: Pharmacokinetics of trimethoprim\u2013sulfamethoxazole in critically ill and non-criticallyill AIDS patients. <i>Antimicrob Agents Chemother<\/i>. <b>39<\/b>: 28-33, 1995.","DOI":"10.1128\/AAC.39.1.28"},{"key":"11","unstructured":"11) \u30d0\u30af\u30c8\u30e9\u30df\u30f3\u914d\u5408\u9320\uff0f\u30d0\u30af\u30c8\u30e9\u30df\u30f3\u914d\u5408\u9846\u7c92 \u6dfb\u4ed8\u6587\u66f8\uff0e2014\u5e742\u6708\u6539\u8a02\uff08\u7b2c18\u7248\uff09\uff0e\u4e2d\u5916\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\uff0e"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Walzer, P.D., Smulian, A.G.: Pneumocystis species. In: Mandell, G.L., Bennett, J.E., Dolin, R., editors. Mandell, Douglas, and Bennett&apos;s principles and practice of infectious diseases, 7th Ed., Philadelphia, pp3377-3390, 2010.","DOI":"10.1016\/B978-0-443-06839-3.00270-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Gilroy, S.A., Bennett, N.J.: Pneumocystis pneumonia. <i>Semin Respir Crit Care Med<\/i>. <b>32<\/b>: 775-782, 2011.","DOI":"10.1055\/s-0031-1295725"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Mori, H., et al.: Hyponatremia and\/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole. <i>Intern Med<\/i>. <b>42<\/b>: 665-669, 2003.","DOI":"10.2169\/internalmedicine.42.665"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Babayev, R., et al.: Trimethoprim-associated hyponatremia. <i>Am J Kidney Dis<\/i>. <b>62<\/b>: 1188-1192, 2013.","DOI":"10.1053\/j.ajkd.2013.06.007"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Noto, H., et al.: Severe hyponatremia and hyperkalemia induced by trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia. <i>Intern Med<\/i>. <b>34<\/b>: 96-99, 1995.","DOI":"10.2169\/internalmedicine.34.96"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Teruya, K., et al.: Complications during clinical courses of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. <i>Intern Med<\/i>. <b>40<\/b>: 221-226, 2001.","DOI":"10.2169\/internalmedicine.40.221"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sato, T., et al.: Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases. <i>Mod Rheumatol<\/i>. <b>15<\/b>: 191-197, 2005.","DOI":"10.3109\/s10165-005-0395-9"},{"key":"19","unstructured":"19) Huntsberry, A.M., et al.: Hyponatremia after initiation and rechallenge with trimethoprim-sulfamethoxazole in an older adult. <i>Clin Interv Aging<\/i>. <b>10<\/b>: 1091-1096, 2015."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Greenberg, S., et al.: Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. <i>Ann Intern Med<\/i>. <b>119<\/b>: 291-295, 1993.","DOI":"10.7326\/0003-4819-119-4-199308150-00007"},{"key":"21","unstructured":"21) \u548c\u7530\u9054\u5f66\uff0c\u4ed6\uff1a\u81a0\u539f\u75c5\u3068\u305d\u306e\u985e\u7e01\u75be\u60a3\u60a3\u8005\u306e\u30b9\u30c6\u30ed\u30a4\u30c9\u5927\u91cf\u7642\u6cd5\u4e2d\u306b\u304a\u3051\u308b\u30cb\u30e5\u30fc\u30e2\u30b7\u30b9\u30c1\u30b9\u80ba\u708e\u767a\u75c7\u4e88\u9632\u306b\u5bfe\u3059\u308bST\u5408\u5264\u306e\u52b9\u679c\u3068\u526f\u4f5c\u7528\u306e\u691c\u8a0e\uff0e\u5317\u91cc\u533b\u5b66\uff0e<b>44<\/b>: 97-102, 2014."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Ho, J.M., Juurlink, D.N.: Considerations when prescribing trimethoprim-sulfamethoxazole. <i>CMAJ<\/i>. <b>183<\/b>: 1851-1858, 2011.","DOI":"10.1503\/cmaj.111152"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Yoshizawa, S., et al.: 5-day course of oral desensitization to trimethoprim\/sulfamethoxazole (T\/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T\/S. <i>Ann Allergy Asthma Immunol<\/i>. <b>85<\/b>: 241-244, 2000.","DOI":"10.1016\/S1081-1206(10)62474-X"}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["\u81ea\u5df1\u514d\u75ab\u6027\u75be\u60a3\u306b\u5408\u4f75\u3057\u305f\u30cb\u30e5\u30fc\u30e2\u30b7\u30b9\u30c1\u30b9\u80ba\u708e\u306b\u5bfe\u3059\u308b\u4e2d\u7b49\u91cfST\u5408\u5264\u3092\u7528\u3044\u305f\u6cbb\u7642\u306e\u526f\u4f5c\u7528\u3068\u4e88\u5f8c"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/39\/3\/39_213\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T17:17:44Z","timestamp":1568049464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/39\/3\/39_213\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.39.213","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}